Pfizer India Temporarily Discontinues Premarin Vaginal Cream

Pfizer Ltd has responded to a clarification request regarding a news item about the discontinuation of Premarin Vaginal Cream in India. The company stated that the imported product has been temporarily suspended due to supply constraints and that they are actively working to restore supply. Pfizer emphasized that Premarin Vaginal Cream contributes less than 1% to the company's revenue and its temporary discontinuation is not expected to have a material impact on financial performance, business operations, or profitability. The company also clarified that this event did not constitute a material event requiring disclosure under SEBI regulations.